LALCA 2023 Highlights


The Latin American Conference on Lung Cancer, held in Uruguay, wrapped up in late January. To provide a summary of key findings from the meeting, Lung Cancer Considered host Dr. Narjust Florez interviewed two prominent oncologists from South America: 

Dr. Clarissa Mathias is a medical oncologist and director of NOB/Oncoclinicas in Brazil. She is a member of the ASCO International Quality Steering Group and Lung cancer committee. Dr. Mathias served on the IASLC board and has led many efforts in thoracic oncology in Brazil and recently hosted an episode of Lung Cancer Considered in Portuguese.

Dr. Carlos Barrios was born in Uruguay but is a practicing oncologist in Brazil. Dr. Barrios is Director and Principal Investigator of the Oncology Research Center at Hospital São Lucas, Pontifical Catholic University of Rio Grande do Sul since 1996, where he has participated in more than 300 clinical research trials during the past 15 years. He is the Director of Clinical Research and Oncologist of the Oncoclínicas Group in Porto Alegre. He is an Adjunct Assistant Professor at the William Harrington Latin American Program of the University of Miami School of Medicine.

Narjust Florez
Narjust Florez


Associate Director of the Cancer Care Equity Program and Assistant Professor of Medicine
Dana-Farber Cancer Institute
Harvard Medical School
Carlos Barrios
Carlos H. Barrios
Director and Principal Investigator
Hospital São Lucas
Pontifical Catholic University of Rio Grande do Sul
Image of Dr. Mathias in White Coat
Clarissa Mathias


Medical Oncologist, NOB/Oncoclinicas and Hospital Santa Izabel; President Brazilian Society of Clinical Oncology; Chair of IAC ASCO